CINECA IRIS Institutional Research Information System

SALERNO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.229
AS - Asia 3.766
EU - Europa 3.563
SA - Sud America 512
AF - Africa 189
OC - Oceania 19
Totale 15.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.024
IT - Italia 1.413
SG - Singapore 1.200
CN - Cina 1.129
HK - Hong Kong 582
SE - Svezia 562
DE - Germania 446
BR - Brasile 428
BG - Bulgaria 228
TR - Turchia 202
GB - Regno Unito 193
VN - Vietnam 168
CA - Canada 162
AT - Austria 140
FI - Finlandia 124
RU - Federazione Russa 118
UA - Ucraina 107
IN - India 106
JP - Giappone 97
KR - Corea 86
FR - Francia 64
CI - Costa d'Avorio 55
NG - Nigeria 33
BD - Bangladesh 32
CH - Svizzera 31
NL - Olanda 29
MX - Messico 28
BE - Belgio 24
ZA - Sudafrica 24
AR - Argentina 23
SN - Senegal 23
PK - Pakistan 22
IQ - Iraq 20
PL - Polonia 20
ID - Indonesia 18
AU - Australia 17
CZ - Repubblica Ceca 15
VE - Venezuela 15
EC - Ecuador 14
EG - Egitto 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
ES - Italia 11
KE - Kenya 11
CO - Colombia 9
JO - Giordania 9
MY - Malesia 9
AZ - Azerbaigian 8
IE - Irlanda 8
KZ - Kazakistan 8
MA - Marocco 8
PE - Perù 7
CL - Cile 6
DZ - Algeria 6
GR - Grecia 6
TW - Taiwan 6
OM - Oman 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
LB - Libano 4
LT - Lituania 4
PY - Paraguay 4
AL - Albania 3
DO - Repubblica Dominicana 3
IL - Israele 3
PH - Filippine 3
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
ME - Montenegro 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SO - Somalia 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LR - Liberia 1
LU - Lussemburgo 1
Totale 15.264
Salva come PNG Salva come JPEG
Città #
Ashburn 765
Woodbridge 746
Singapore 654
Ann Arbor 631
Houston 603
Hong Kong 571
Serra 508
Santa Clara 460
Chandler 440
Fairfield 404
Dallas 332
Milan 281
Shanghai 229
Sofia 228
Beijing 227
New York 183
Seattle 180
Wilmington 173
Jacksonville 140
Izmir 137
Ottawa 132
Los Angeles 130
Cambridge 129
Boardman 128
Hefei 119
Vienna 114
Princeton 111
Lawrence 97
London 86
Seoul 86
Nanjing 79
Medford 78
Frankfurt am Main 77
Abidjan 55
Des Moines 55
Pisa 53
Dong Ket 52
Munich 52
Istanbul 51
Dearborn 46
Rho 45
Council Bluffs 41
Redondo Beach 41
Rome 40
São Paulo 39
Buffalo 36
San Jose 36
Tokyo 35
Düsseldorf 34
Boulder 31
Lagos 31
Turku 30
Bremen 29
Bern 26
Jüchen 25
Brussels 24
Pune 24
Dakar 23
Florence 23
Kunming 23
Nanchang 23
Redwood City 23
Ho Chi Minh City 22
Changsha 20
The Dalles 20
San Diego 19
Columbus 18
Fuzhou 18
Ogden 18
San Francisco 18
Belo Horizonte 17
Hebei 17
Nürnberg 17
Shenyang 17
Warsaw 16
Washington 16
Helsinki 15
Lucca 15
Chicago 14
Johannesburg 14
Aversa 13
Hanoi 13
Livorno 13
Jinan 12
Tashkent 12
Toronto 12
Guangzhou 11
Jiaxing 11
Norwalk 11
Nuremberg 11
Pessac 11
Phoenix 11
Quanzhou 11
Stockholm 11
Vercelli 11
Amsterdam 10
Rio de Janeiro 10
Vicopisano 10
Amman 9
Chennai 9
Totale 10.837
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 383
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 266
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 257
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 219
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 214
An update into the medicinal chemistry of translocator protein (TSPO) ligands 201
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 198
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 196
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 189
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 189
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 186
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 183
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 183
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 183
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 182
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 181
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 181
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 179
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 175
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 174
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 173
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 173
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 172
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 171
FACILE SYNTHESIS OF 3-SUBSTITUTED[1,2,4]TRIAZINO[3,4-F]PURINE-4,6,8-TRIONE DERIVATIVES 170
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 169
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 168
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 166
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 164
Synthesis of novel 1,4-dihydropyrido[3’,2’:5,6]thiopyrano[4,3-c]-pyrazoles and 5H-pyrido[3’,2’:5,6]thiopyrano[4,3-d]pyrimidines as potential antiproliferative agents 163
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 163
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 162
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 160
Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents 158
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 157
Synthesis and antiproliferative evaluation of new aryl substituted Pyrido[3’,2’:5,6]thiopyrano[4,3-c]pyrazoles 157
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 156
Mitochondrial permeability transition induced by novel pyridothiopyranopyrimidine derivatives: Potential new antimitochondrial antitumour agents. 155
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 154
Spirohydantoin Derivatives of Thiopyrano[2,3-b]pyridin-4(4H)-one as Potent in Vitro and in Vivo Aldose Reductase Inhibitors 153
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 153
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 152
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 151
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 148
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 148
Carbonic anhydrase activation profile of indole-based derivatives 148
Derivati spiroidantoinici del Tiopirano[2,3-b]piridin-4(4H)-one quali potenti inibitori dell’aldoso reduttasi 146
Novel Aldose Reductase Acetic acid Inhibitors Bearing a Five Membered heterocyclic core 146
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 146
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 143
Novel Antitumoral Pyrazolopyrimidines Based on Inhibition of Protein Tyrosine Kinase 143
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 143
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 142
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 141
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 137
"Synthesis of purinobenzodiazepine and purinobenzotriazocine derivatives, two new heterocyclic ring system" 136
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 135
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 135
Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization 134
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 131
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 130
Synthesis and biological evaluation of Modified 2-Phenylindol-3-ylglyoxylamides as good candidates for the development of radioligands for the visualization of peripheral benzodiazepine receptor 129
Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis 129
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 128
Design, Synthesis, and Biological Evaluation of 3-Arylindazole Acetic Acid Derivatives as Aldose Reductase Inhibitors 127
Exploiting the pyrazolo[3,4-d]pyrimidinone ring system as a useful template for the obtainment of potent adenosine deaminase inhibitors 127
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 127
New oxazole and 1,2,4-oxadiazole derivatives as selective ligands at the Translocator Protein (TSPO) 126
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 125
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 124
"Synthesis of pyridothiopyranoindole and of pyridothiopyranoquinoline derivatives as novel tetracyclic ring system" 124
Pyridopyrimidinone Derivatives as Novel Therapeutic Agents for the Topic Treatment of Vessel Walls Subjected to Percutaneous Intervention 123
SYNTHESIS OF NOVEL 5H,11H-PYRIDO[2',3':2,3]THIOPIRANO[4,3-B]-INDOLES BY FISCHER-INDOLE CYCLIZATION. 120
Design, synthesis, and biological evaluation of novel fluorescent probes targeting the Translocator Protein (18 kDa) (TSPO) 119
Novel Pyrazolopyrimidine Derivatives as Therapeutic Agents for the Treatment of Medullary Thyroid Carcinoma 118
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit a- and ß-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms 118
"Synthesis, DNA binding and in vitro antiproliferative activity of quinazobenzimidazole derivatives as potential antitumor agents". 116
High Affinity Central Benzodiazepine Receptor Ligands: Synthesis and Biological Evaluation of a Series of Phenyltriazolobenzotriazindione Derivatives (PTBTs) 116
NOVEL KINASE INHIBITORS IN THYROID CANCER TREATMENT: SYNTHESIS AND BIOLOGICAL EVALUATION 113
Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents 113
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 112
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 112
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 111
Targeting the Translocator protein (TSPO) with 2-phenylindol-3-ylglyoxylamide derivatives 110
Substituted 2-Arylindolglyoxylamides as Potent Translocator Protein (18 kDa) TSPO ligands: Synthesis and Biological Evaluation 107
Synthesis and Antiproliferative Activity of New Aminoalkyl Substituted Benzothiopyranoindoles 106
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo[3,4-d]pyrimidine adenosine A(3) receptor antagonists. 106
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 105
Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 104
TSPO Radioligands for Neuroinflammation: An Overview 104
"Sintesi e attività antiproliferativa di sistemi Pirido[3’,2’:5,6]tiopirano[4,3-c]pirazolici 2-aril sostituiti" 104
Synthesis and in vitro Antiproliferative Activity of New Substituted Benzo[3',2':5,6]thiopyrano[4,3-d]pyrimidines 99
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 96
"Facile sintesi di nuove molecole polieterocicliche a partire dal 2-guanidinobenzimidazolo" 96
Novel 3-Aryl-1,2,4triazino4,3-abenzimidazol-4(10H)-ones (ATBI) as selective A2A adenosine receptor antagonists 94
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo3,4-Dpyrimidine adenosine A3 receptor antagonists 92
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 92
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 89
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 87
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 87
Totale 14.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021409 0 0 0 0 0 31 34 63 60 43 49 129
2021/20221.155 40 95 53 69 178 150 37 51 41 37 57 347
2022/20231.631 198 281 115 147 202 202 18 114 263 6 64 21
2023/20241.347 144 134 150 92 161 275 102 49 12 22 88 118
2024/20253.690 30 124 44 230 428 412 258 184 336 459 394 791
2025/20262.359 258 480 461 328 485 347 0 0 0 0 0 0
Totale 15.541